Tag Archives: SARS-CoV-2

Bharat Biotech’s Covid-19 vaccine will use ViroVax’s adjuvant for longer-lasting immunity

Leading vaccine Bharat Biotech announced Monday that its Covaxin vaccine against coronavirus disease (Covid-19) will use the adjuvant Alhydroxiquim-II to stimulate the immune response. An adjuvant is a pharmacological or immunological agent that enhances the immune response of a vaccine by producing more antibodies and providing longer-lasting immunity. Kansas-based ViroVax …

Read More »